Zolsoma 5 Tablet is a combination medication containing Melatonin 3 mg and Zolpidem 5 mg, primarily indicated for the short-term management of insomnia characterized by difficulty in sleep initiation and maintenance. Melatonin, a naturally occurring hormone, helps regulate the circadian rhythm, promoting the onset of sleep, while Zolpidem, a non-benzodiazepine hypnotic agent, acts selectively on the GABA-A receptor complex to induce sedation and facilitate sleep. This dual-action formulation provides both the physiological regulation of sleep-wake cycles and pharmacological sedation, enhancing overall sleep quality. Zolsoma 5 is typically prescribed for adults experiencing transient or chronic insomnia where non-pharmacological measures have proven inadequate. The recommended dosage should be taken orally, immediately before bedtime, to maximize efficacy and minimize residual daytime sedation. Caution is advised in patients with hepatic or renal impairment, respiratory disorders, or a history of substance abuse. Common adverse effects may include dizziness, headache, and gastrointestinal disturbances. Due to the potential for dependence and tolerance, it is recommended for short-term use under strict medical supervision. Patients should avoid alcohol and operating heavy machinery while on this medication. Consultation with a healthcare professional is essential before initiating therapy with Zolsoma 5 Tablet.